Sec. 8. Including antifungal products in the CARB–X program
92 words·~1 min read·
/bill/115/hr/6562/ih/section-8A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of Health and Human Services shall, in carrying out the Combating Antibiotic Resistant Bacteria Accelerator program of the Department of Health and Human Services (commonly referred to as CARB–X ), conduct research with respect to antifungal resistance, including therapies, diagnostics, and vaccines, including for coccidioidomycosis. There are authorized to be appropriated to the Biodefense Medical Countermeasure Development Fund established under section 319L(d) of the Public Health Service Act (42 U.S.C. 247d–7e(d)) to carry out subsection
(a)$10,000,000 for each of fiscal years 2019 through 2024, to remain available until expended.
Connections1 off-index
1 reference not yet in our index
- 42 USC 247d–7e(d)
Citation graph
cites case law
Sec. 8
Including antifungal products in the CARB–X program
Cite42 USC 247d–7e(d)
Cites 1Cited by 0 across 0 sources